Back to articles
Comparative guide · 5 min read

Quercetin vs Bromelain — which one fits which inflammatory complaint?

Updated 2026-05-10 · Reviewed by SupplementScore editors · No sponsorships

These two are routinely sold together — quercetin + bromelain combinations are practically a category of their own. They have very different mechanisms and very different best-evidence indications. Quercetin is the antihistamine-adjacent flavonoid with the better data in allergic rhinitis, mast cell complaints, and exercise-related immune support. Bromelain is the proteolytic enzyme with the better data in post-surgical edema, sinus inflammation, and certain musculoskeletal recovery contexts. The combination products often have sub-therapeutic doses of each.

Quick verdict

ComplaintBetter choiceWhy
Seasonal allergic rhinitis Quercetin (or quercetin phytosome) Mast cell stabilisation; small trial signals at 500 mg b.i.d. of quercetin phytosome.
Post-surgical swelling and bruising Bromelain Best-evidenced indication; trials in dental, ENT, and orthopaedic post-op show modest reductions in edema.
Acute sinusitis (adjunct) Bromelain Some trial support as adjunct to standard care; not a substitute for antibiotics when indicated.
Mast cell activation symptoms Quercetin The MCAS literature includes quercetin as a commonly trialled adjunct; rigorous trial evidence is limited.
Knee osteoarthritis pain Bromelain (modest) Some short-term symptomatic benefit; effect size smaller than NSAIDs.
Exercise immune dip post heavy training Quercetin Trials in endurance athletes show small reductions in upper-respiratory infection rates.

How they compare on the things that matter

Mechanism — flavonoid vs proteolytic enzyme

Quercetin is a flavonoid found in onions, capers, apples, and tea. Its anti-inflammatory mechanisms include mast cell stabilisation (reducing histamine release in IgE-mediated allergic responses), inhibition of pro-inflammatory cytokines, and antioxidant activity. The native compound has poor oral bioavailability; phytosome formulations (quercetin bound to phosphatidylcholine) substantially improve absorption and are the form used in many recent positive trials.

Bromelain is a mixture of proteolytic enzymes from the pineapple plant. Its proposed mechanisms include direct fibrinolytic activity, modulation of bradykinin pathways involved in edema formation, and modulation of cell-surface adhesion molecules. Unlike quercetin, bromelain is most active when taken on an empty stomach — taking it with food largely diverts it to digesting the meal rather than acting systemically.

Evidence base by clinical endpoint

Practical rule. If your complaint is allergic or mast-cell-driven (sneezing, watery eyes, hives, exercise-induced URI), quercetin is the better fit — the phytosome form at 500 mg b.i.d. has the cleanest current trial signal. If your complaint is post-procedural swelling, sinus pressure or musculoskeletal post-injury inflammation, bromelain is the better fit, taken on an empty stomach away from meals.

Dose and form

For quercetin, native quercetin requires 500–1000 mg/day to achieve modest plasma concentrations due to poor absorption. The phytosome form (quercetin Phytosome / Lipocaps / Quercetin LipoMicel) is dosed at 250–500 mg b.i.d. with substantially better bioavailability — and the recent positive trials have used these formulations. Take with a fat-containing meal (the phospholipid-bound form benefits from biliary secretion stimulation).

For bromelain, dose is most usefully reported in GDU (gelatin digesting units) or MCU (milk clotting units) rather than mg, because preparations vary widely in enzymatic activity. Trial doses run 200–800 mg/day at 1500–2400 GDU/g activity. Take on an empty stomach (60+ minutes before or after meals) for systemic anti-inflammatory effect; with meals, it just digests dietary protein.

Safety

Quercetin is generally well-tolerated. The main practical caution is interaction with cyclosporine (it can substantially increase cyclosporine levels) and theoretical interactions with other CYP3A4-metabolised drugs at higher doses. Pregnancy and lactation safety data are limited at supplemental doses.

Bromelain is generally well-tolerated. The main cautions are: theoretical additive antiplatelet effect with anticoagulants, theoretical potentiation of antibiotic absorption (relevant for some antibiotics), and pineapple allergy as a contraindication. GI upset and rare allergic reactions are the most common adverse effects.

What the price difference buys you

Quercetin (native powder) runs $0.20–0.40/day. Quercetin phytosome runs $0.50–1.00/day. Bromelain runs $0.20–0.50/day. The combination quercetin + bromelain "immune support" products typically charge premium prices for sub-therapeutic doses of each — read the doses carefully.

Who should skip each

Quercetin should be approached cautiously in pregnancy, in users on cyclosporine or other CYP3A4-metabolised immunosuppressants, and at very high doses (1+ g/day chronically) in users with chronic kidney disease.

Bromelain should be avoided in pineapple allergy, approached cautiously in users on anticoagulants (warfarin, DOACs, antiplatelets) due to additive bleeding risk, and discontinued at least 2 weeks before scheduled surgery for the same reason.

What we'd actually buy

For seasonal allergies as an adjunct to standard antihistamines: quercetin phytosome 250–500 mg twice daily, started ahead of the typical pollen window.

For post-procedural swelling (post-dental extraction, post-sinus surgery, post-orthopaedic surgery), with surgeon sign-off: bromelain 500 mg three times daily on an empty stomach for 5–7 days post-operatively.

For combined allergic-and-musculoskeletal complaints: standalone quercetin phytosome and standalone bromelain at the doses above, taken at different times of day. The combo products often deliver sub-therapeutic doses of each — read the label.

Sources

Read more: